Cite
MLA Citation
F. Spriano et al.. “The first-in-class WASP activator EG-011 is active in lymphoma and multiple myeloma cell lines resistant to FDA approved compounds.” European journal of cancer, vol. 174, n.d., pp. S107–. http://access.bl.uk/ark:/81055/vdc_100168600609.0x000038